After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Four mobile phone numbers threatening the 26/11 terror attacks, shared on the WhatsApp number of
Salman Khan Firing Case More new revelations have been made in the firing case at Bollywood super
The third day of the Paris Olympics was a mixed one for India. On Monday, Manu Bhaker and Sarabjo
GDP: Growth rate revised to 9.1 percent for 2021-22, to grow at 7% in 2022-23
The government has revised the economic growth rate for the year 2021-22 from 8.7 percent to 9.1
The third match of the 5-match T20 series being played between India and South Africa will be pla
Britain on the way to Pakistan: Prohibition on buying more than 2 potatoes, tomatoes; Why are fruits and vegetables disappearing from the market?
Britain is also on the path of Pakistan. There is also a shortage of fruits and vegetables here. Ala
Amidst the ongoing cruise drugs party case in Mumbai, the team of the Directorate of Revenue Inte
Pakistan: Polio cases increasing continuously in Pakistan, a campaign started again
A new nationwide anti-polio campaign was launched in Pakistan on Monday. This campaign has been s
Corona Cases In India: The cases of corona in the country have started increasing once again. The
Pakistan has suffered about $28 billion in damages from the devastating floods. It will take two
